| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 27.248 | 14.766 | 1.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 45.510 | 4.687 | 1.290 | 18 | 2 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -18.263 | 10.079 | 76 | -18 | -2 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -19.080 | 9.636 | 34 | -18 | -2 | 0 | 0 | 0 | 0 | 0 |
| Employees | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Nora Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.142 | 1.068 | 1.023 | 986 | 965 | 947 | 926 | 929 | 926 | 921 |
| Current Assets | 20.902 | 17.958 | 16.308 | 16.009 | 14.834 | 14.553 | 14.230 | 14.275 | 14.231 | 14.152 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18.600 | 17.707 | 16.268 | 15.969 | 14.830 | 14.549 | 14.226 | 14.270 | 14.227 | 14.147 |
| Cash | 2.301 | 252 | 40 | 39 | 5 | 5 | 4 | 4 | 4 | 4 |
| Shareholders Funds | -127.987 | -117.046 | -115.031 | -112.938 | -110.753 | -108.653 | -106.244 | -106.573 | -106.250 | -105.656 |
| Social Capital | 79 | 78 | 77 | 75 | 74 | 72 | 71 | 71 | 71 | 70 |
| Debts | 150.030 | 136.072 | 132.362 | 129.933 | 126.552 | 124.153 | 121.400 | 121.777 | 121.407 | 120.729 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Bio Nora Srl